Why I Joined Solid?

Board of Directors

Our Board of Directors has a wide range of expertise, from drug development to business management. We bring sharp commercial focus and world-class science together to advance promising therapies.

Ilan Ganot
Co-Founder, President and CEO

Ilan Ganot

Andrey Zarur
Co-Founder and Chairman of the Board

Andrey Zarur, Ph.D.

Robert Huffines
Global Chairman of Investment Banking at J.P. Morgan

Robert Huffines

Lynne Sullivan
Chief Financial Officer, Compass Therapeutics

Lynne Sullivan

Co-Founder and Board Member

Matt Arnold

Adam Stone
Chief Investment Officer of Perceptive Advisors

Adam Stone

Adam Koppell
Managing Director of Bain Capital Life Sciences

Adam Koppel, M.D., Ph.D.

Raj Shah
Portfolio Manager and Managing Director of RA Capital Management

Rajeev Shah

Board Member

Martin Freed, MD, FACP

Board Member

Sukumar Nagendran, MD

Management Team

Our management team has the breadth of experience and passion to bring meaningful therapies to patients with Duchenne muscular dystrophy.

Ilan Ganot
Co-Founder, President and CEO

Ilan Ganot

Alvaro Amorrortu
Chief Operating Officer

Alvaro Amorrortu

Jorge A. Quiroz
Chief Medical Officer

Jorge A. Quiroz, M.D.

Joel Schnieder
Chief Technology Officer, Head of Exploratory Research & Development

Joel Schneider, Ph.D.

Carl Morris
Chief Scientific Officer

Carl Morris, Ph.D.

Chief Financial Officer

Jennifer Ziolkowski, CPA

Scientific Advisors

Solid Biosciences has assembled a world-class team of experts comprised of leading immunologists, molecular biologists, clinicians and gene therapy researchers. Together, these field-leading authorities are helping Solid progress our candidates into the clinic.

Medical College of Wisconsin

Michael Lawlor, M.D., Ph.D.

Dongsheng Duan
University of Missouri

Dongsheng Duan, Ph.D.

Dr.Jeff Chamberlain
University of Washington

Jeff Chamberlain, Ph.D.

Ronald D. Cohn, M.D
Sick Kids

Ronald D. Cohn, M.D.

Carrie MicelIi
UCLA

Carrie Miceli, Ph.D.

Laurence Turka
Massachusetts General Hospital

Laurence A. Turka, M.D.

Jeff Bluestone
UCSF

Jeff Bluestone, Ph.D.

Geoffrey Slaff
Scientific Advisory Board

Geoffrey Slaff, Ph.D.

Dr. Lee Sweeney, PhD
Consultant

Lee Sweeney, Ph.D.

Joe Kornegay
Consultant

Joe Kornegay, Ph.D.

James M. Ervasti
Consultant

James M. Ervasti, Ph.D.

Our Founders

Solid is the English translation of Eytani, the Hebrew name of Ilan and Annie Ganot’s son, who was diagnosed with Duchenne muscular dystrophy in 2012. 

Following this diagnosis, Ilan and Annie co-founded Solid Biosciences with our Chairman of the Board, Andrey Zarur, Matt Arnold and Gilad Hayeem, who were all unsatisfied with the existing Duchenne treatment landscape. Together, they built a disease-focused company with the team, infrastructure and potential to advance innovative science quickly and responsibly.

Ilan Ganot
Co-Founder, President and CEO

Ilan Ganot

Co-Founder and Patient Advocacy

Annie Ganot

Gilad Hayeem
Co-Founder

Gilad Hayeem

Andrey Zarur
Co-Founder and Chairman of the Board

Andrey Zarur, Ph.D.

Co-Founder and Board Member

Matt Arnold

More information about Solid?

Please subscribe to receive our latest news